Pharmacists across the United Kingdom have reported shortages of the meningitis B (MenB) vaccine ahead of a new NHS immunisation programme targeting young adults. The campaign, set to begin tomorrow, aims to offer the vaccine to approximately one million Year 13 students and under-25s starting university this autumn.

The initiative follows recent outbreaks of meningitis B, which resulted in the deaths of two teenagers in Kent earlier this year. Health officials introduced the one-off vaccination drive to help curb the spread of the disease among students, who are considered at heightened risk in communal living environments such as university dormitories.

The National Pharmacy Association, representing around 6,000 community pharmacies, has raised concerns over limited vaccine supplies. Some member pharmacies reported difficulties in meeting the demand generated by the programme, with insufficient stock to cover all booked appointments scheduled for the coming week.

The shortage poses challenges to the NHS’s efforts to ensure timely vaccination for all eligible students. Pharmacy leaders have called for urgent measures to increase vaccine availability and prevent disruptions that could undermine the campaign’s success.

Health authorities have emphasised the importance of the vaccination programme in reducing meningitis B incidences and protecting vulnerable populations. However, with supply constraints affecting some areas, officials are monitoring the situation closely to manage distribution and address any emerging gaps in coverage.

The MenB vaccine is delivered as a precaution against meningitis B bacteria, which can cause severe infections including meningitis and septicaemia. The heightened risk among young adults living in close quarters has prompted targeted immunisation strategies in recent years.

As the vaccination drive begins, public health agencies continue to urge eligible individuals to receive the vaccine promptly while supplies last. The NHS and pharmacy groups are working to alleviate shortages and facilitate access to the vaccine for students ahead of the academic year.